Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asolva is a healthcare software company focused on antimicrobial stewardship, hospital workflow optimization, and clinical data mining. Its flagship product, MEDICI, is a cloud-based antimicrobial stewardship and reporting platform used by hospitals to support antimicrobial use and resistance reporting, antibiograms, clinical guidelines, prospective audits, and related medication data workflows. The company built its offering to integrate with hospital EHR systems and serve a range of care settings, including multi-site systems and critical access hospitals. In March 2023, Asolva was acquired by Harris Computer and became part of Harris OnPoint, where its MEDICI product continues to be marketed commercially. Asolva is healthcare-related, but it is not a biotech or therapeutic drug developer; it operates in healthcare IT and infection-management software.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Asolva.